Invesco’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-118,310
| Closed | -$16.6M | – | 3940 |
|
|
2018
Q4 | $16.6M | Sell |
118,310
-70,616
| -37% | -$10.7M | 0.01% | 1240 |
|
|
2018
Q3 | $32.3M | Buy |
188,926
+86,005
| +84% | +$14.5M | 0.01% | 1012 |
|
|
2018
Q2 | $17.9M | Buy |
102,921
+22,507
| +28% | +$3.38M | 0.01% | 1310 |
|
|
2018
Q1 | $9.28M | Sell |
80,414
-87,099
| -52% | -$9.26M | ﹤0.01% | 1592 |
|
|
2017
Q4 | $14.1M | Buy |
167,513
+110,083
| +192% | +$9.18M | 0.01% | 1394 |
|
|
2017
Q3 | $5.29M | Buy |
57,430
+28,008
| +95% | +$2.18M | ﹤0.01% | 1934 |
|
|
2017
Q2 | $2.36M | Buy |
+29,422
| New | +$1.63M | ﹤0.01% | 2438 |
|
|
2017
Q1 | – | Sell |
-28,269
| Closed | -$908K | – | 3789 |
|
|
2016
Q4 | $908K | Sell |
28,269
-4,850
| -15% | -$124K | ﹤0.01% | 3044 |
|
|
2016
Q3 | $867K | Buy |
+33,119
| New | +$867K | ﹤0.01% | 3017 |
|
|
2016
Q2 | – | Sell |
-55,593
| Closed | -$1.52M | – | 3755 |
|
|
2016
Q1 | $1.52M | Sell |
55,593
-28,550
| -34% | -$597K | ﹤0.01% | 2642 |
|
|
2015
Q4 | $2.39M | Buy |
84,143
+3,298
| +4% | +$88.5K | ﹤0.01% | 2405 |
|
|
2015
Q3 | $1.41M | Buy |
80,845
+80,566
| +28,877% | +$1.58M | ﹤0.01% | 2728 |
|
|
2015
Q2 | $5K | Buy |
+279
| New | +$3.81K | ﹤0.01% | 4250 |
|
Other funds holding LOXO
Invesco's LOXO Position: Q1 2019 in Review
Invesco sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 118,310 shares — an estimated $16.6M sold.
Invesco first reported a position in LOXO in Q2 2015 and held it in 13 quarters. The position peaked at $32.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- Invesco reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- Invesco sold 118,310 Loxo Oncology, Inc shares in Q1 2019, an estimated $16.6M.
- Invesco first reported a position in Loxo Oncology, Inc in Q2 2015 and held it in 13 quarters.
- Invesco's Loxo Oncology, Inc position peaked at $32.3M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on Invesco's 13F filing for Q1 2019, filed 15 May 2019.